Volta Labs
A leading pharmaceutical company in Amyotrophic Lateral Sclerosis (ALS) is interested in speaking with startups whose technology could contribute to very early diagnosis of the disease.
Epoch Garage + is delighted to announce that the “Startup Global Program-- F23 Batch” is now open for application